EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

Por CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Publicado no Oncol Lett (2015)

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

Por Casadei Gardini, Andrea, Mariotti, Marita, Lucchesi, Alessandro, Pini, Sara, Valgiusti, Martina, Bravaccini, Sara, Del Monte, Angelo, Burgio, Marco Angelo, Marisi, Giorgia, Amadori, Dino, Frassineti, Giovanni Luca
Publicado no BMC Cancer (2016)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Por Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

Por Ulivi, Paola, Capelli, Laura, Valgiusti, Martina, Zoli, Wainer, Scarpi, Emanuela, Chiadini, Elisa, Rosetti, Paola, Bravaccini, Sara, Calistri, Daniele, Saragoni, Luca, Casadei Gardini, Andrea, Ragazzini, Angela, Frassineti, Giovanni Luca, Amadori, Dino, Passardi, Alessandro
Publicado em 2012

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

Por Faloppi, Luca, Del Prete, Michela, Gardini, Andrea Casadei, Santini, Daniele, Silvestris, Nicola, Bianconi, Maristella, Giampieri, Riccardo, Valgiusti, Martina, Brunetti, Oronzo, Bittoni, Alessandro, Andrikou, Kalliopi, Lai, Eleonora, Dessì, Alessandra, Cascinu, Stefano, Scartozzi, Mario
Publicado no Sci Rep (2016)

Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions

Por Gardini, Andrea Casadei, Tenti, Elena, Masini, Carla, Nanni, Oriana, Scarpi, Emanuela, Valgiusti, Martina, Restuccia, Silvia, Gallani, Maria Laura, Palazzini, Simonetta, Bianchini, Erica, Menozzi, Silvia, Maugeri, Antonio, Amadori, Dino, Minguzzi, Martina, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

Por Casadei Gardini, Andrea, Foca, Flavia, Scartozzi, Mario, Silvestris, Nicola, Tamburini, Emiliano, Faloppi, Luca, Brunetti, Oronzo, Rudnas, Britt, Pisconti, Salvatore, Valgiusti, Martina, Marisi, Giorgia, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Tassinari, Davide, Cascinu, Stefano, Frassineti, Giovanni Luca
Publicado no Sci Rep (2017)

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

Por Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)